Short answer · Medically reviewed summary · Last updated: 2023-07-13
Bethlem Myopathy is a rare genetic disorder that falls under the category of collagen VI-related myopathies. It is characterized by muscle weakness and joint stiffness, primarily affecting the skeletal muscles.
1 people with Bethlem Myopathy have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Bethlem Myopathy?
Prevalence of Bethlem Myopathy: how many people are affected worldwide, differences by sex and region, with sources.
Bethlem Myopathy is a rare genetic disorder that falls under the category of collagen VI-related myopathies. It is characterized by muscle weakness and joint stiffness, primarily affecting the skeletal muscles. The prevalence of Bethlem Myopathy is estimated to be around 1 in 300,000 to 500,000 individuals worldwide.
This condition is inherited in an autosomal dominant manner, meaning that a person with the mutated gene has a 50% chance of passing it on to their children. Bethlem Myopathy typically presents in childhood or early adulthood, with symptoms varying in severity among affected individuals.
While the exact cause of Bethlem Myopathy is still being studied, mutations in the COL6A1, COL6A2, and COL6A3 genes have been identified as contributing factors. These genes provide instructions for producing collagen VI, a protein that plays a crucial role in maintaining the structure and function of connective tissues in the body.
Diagnosis of Bethlem Myopathy involves a combination of clinical evaluation, genetic testing, and muscle biopsies. Although there is currently no cure for this condition, management strategies focus on alleviating symptoms and improving quality of life through physical therapy, assistive devices, and regular monitoring of respiratory and cardiac functions.
I THINK THAT IT AFFECTS ONE PERSON PER MILLION
Posted Oct 21, 2017 by IGNACIO 3050
